In the REDEFINE 1 phase 3 trial, cagrilintide 2.4 mg monotherapy produced an average body weight reduction of 11.8% over 68 weeks
As we age, the body produces less BPC-157, which can slow recovery from injuries and other conditions
First isolated from cerebral venous blood in 1977, it gets its name from early research showing it could promote delta-wave sleep the deepest, most restorative stage of sleep associated with physical recovery and growth hormone release
Supplied as a 50 mg vial for in-vitro laboratory research use only
If you have been following tirzepatide refrigeration protocols , the same general principles apply to retatrutide, but you should review proper peptide storage after reconstitution for the new compound to ensure potency throughout your transition
no single peer-reviewed primary source